Filing Analysis

Articles from US 10-Q and 10-K filings. Pick a sector or search.

aiSwingX™ analyzes US filings and reports them as news investors can read.
–
927
Amazon: 105 Perplexity: 83 Meta AI: 75 Claude: 52 ChatGPT: 46 Google · Gemini: 18 Others: 179
Read by AI & crawlers
Amazon105
Perplexity83
Meta AI75
Claude52
ChatGPT46
Google · Gemini18
Common Crawl1
Others179

Counted by the name each crawler gives. Google · Gemini includes Googlebot, whose index Google also uses for its AI features; other search engines and bots are in Others.

REGN2026Q3 · 10-QPaid

Regeneron Pharmaceuticals' operating margin went from 27.3% to 40.0% as revenue rose 36.3%

Regeneron Pharmaceuticals (REGN) filed its quarterly report (10-Q) for fiscal Q3 2026 on October 30. The operating margin went from 27.3% in the same period a year earlier to 40.0%. Revenue rose 36.3%.

Regeneron Pharmaceuticals
12
11
Read by AI & crawlers
Amazon2
Claude2
ChatGPT2
Perplexity1
Others4
←9 / 30→
Get an email when a new article is outConfirm via the link we email you

Frequently asked questions

How often are articles published?

Mostly during earnings season — an article for each covered company when its 10-Q or 10-K is filed, plus material 8-K filings when relevant.

Can I request a ticker?

Yes. Send a request through Messages after logging in and we will consider it for the next earnings season. License customers may nominate priority tickers.

What is on a ticker page?

The company's articles and a table of key metrics that accumulates quarter by quarter, so the same figure can be compared over time.

aiSwingX™ analyzes US filings and reports them as news investors can read.
–
927
Amazon: 105 Perplexity: 83 Meta AI: 75 Claude: 52 ChatGPT: 46 Google · Gemini: 18 Others: 179
Read by AI & crawlers
Amazon105
Perplexity83
Meta AI75
Claude52
ChatGPT46
Google · Gemini18
Common Crawl1
Others179

Counted by the name each crawler gives. Google · Gemini includes Googlebot, whose index Google also uses for its AI features; other search engines and bots are in Others.